Status:
COMPLETED
Prediction of Outcome in Severe Preeclampsia
Lead Sponsor:
Cairo University
Conditions:
Leiden Factor V Deficiency,Preeclampsia
Doppler Examination
Eligibility:
FEMALE
Brief Summary
this summary studied the predictive values of factor V Leiden mutation , doppler indices , placental pathology to unfavorable fetal and maternal outcomes
Detailed Description
leiden mutation is activated protein C resistance with hypercoagulable states and increased thrombotic risk. 99 % are heterozygous and 1 % is homozygous , very rare cases are psoudohomozygous with fac...
Eligibility Criteria
Inclusion
- severe preeclampsia in 3rd trimester -
Exclusion
- Twin pregnancy. Fetal congenital anomalies. Diabetic patient, impaired renal function. Any medical disorders even that HTN. Any placental pathology,Autoimmune diseases. Women with uterine activity or clinical emergencies with maternal hemodynamic instability or an indication for immediate termination of pregnancy.
- \-
Key Trial Info
Start Date :
December 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2017
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03871764
Start Date
December 1 2015
End Date
April 1 2017
Last Update
March 12 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.